Breast Cancer Patients Face Tamoxifen Shortages, Forcing Cross-Border Treatment Lithuanian women receiving breast cancer treatment are reporting a significant disruption in access to a critical medication, tamoxifen. According to interviews with patients broadcast by the Lithuanian public channel LRT, a four-month lack of the drug has presented considerable challenges to their care. Patients receiving chemotherapy within Lithuanian hospitals have stated that tamoxifen, a commonly prescribed medication for breast cancer treatment, has been unavailable for extended periods. This shortage has necessitated some individuals to travel to Latvia and Poland to obtain the necessary medication. The interviews highlighted the frustration and concern among patients regarding the delay in receiving their prescribed treatment. Representatives from patient support groups have expressed the urgency of the situation, emphasizing the potential impact on treatment efficacy and patient well-being. Officials have not yet released a formal statement addressing the supply issues. However, the reported shortages underscore a critical concern regarding the availability of essential medications for individuals undergoing breast cancer treatment within Lithuania. Further investigation into the cause of the delay and steps to ensure consistent supply are reportedly underway. Topics: #lack #treatment #breast Post navigation General incidence in Estonia is decreasing, but one virus is attacking more and more aggressively Major security hole: now, the door cards of many state institutions and companies can be hacked by even every schoolboy
“It’s heartbreaking to hear patients are being denied essential medication and forced to travel to other countries for care.” Reply